| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 2 | |
| #2 | Australia | 1 | |
| #3 | Brazil | 1 | |
| #4 | Canada | 1 | |
| #5 | China | 1 | |
| #6 | EAPO (Eurasian Patent Organization) | 1 | |
| #7 | EPO (European Patent Office) | 1 | |
| #8 | Israel | 1 | |
| #9 | Republic of Korea | 1 | |
| #10 | Mexico | 1 | |
| #11 | New Zealand | 1 | |
| #12 | Singapore | 1 | |
| #13 | United States | 1 | |
| #14 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Measurement | |
| #3 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Analysing materials | |
| #4 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Horrigan Stephen | 12 |
| #2 | Bhalla Kapil N | 11 |
| #3 | Stephen Horrigan | 3 |
| #4 | Kapil N Bhalla | 3 |
| #5 | Vankayalapati Hariprasad M | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2013071232A1 | Compositions and methods for inhibition of tbl-1 binding to disease-associated molecules | |
| CN103917514A | Methods for treatment of diseases and disorders related to transducin beta-like protein 1 (tbl 1) activity, including myeloproliferative neoplasia and chronic myeloid leukemia |